Serum fibroblast growth factor 21: Lack of association with gestational diabetes and pregnancy outcomes

Table 2 Pregnancy outcomes, n (%)

Outcomes	Non-GDM (n = 81)	Diet-treated GDM (n = 25)	Insulin-treated GDM (n = 3)	P value
Gestational age at delivery in weeks	39 (38-39)	38 (38-39)	38 (33-40)	0.780
Birth weighting	3120 (2880-3320)	3050 (2970-3210)	2630 (1580-3090)	0.150
Placental weighting	580.16 ± 136.85	566.67 ± 119.34	410 ± 101.49	0.098
Fetal sex				> 0.990
Male	40 (49.38)	13 (52.00)	1 (33.33)
Female	41 (50.62)	12 (48.00)	2 (66.67)
Apgar score
5-minute	9 (8-9)	9 (8-9)	9 (9-9)	0.700
10-minute	10 (9-10)	10 (9-10)	10 (10-10)	0.800
Pre-eclampsia	7 (8.64)	2 (8.00)	0	> 0.990
Weight at delivery in kg	68.00 (61.30-76.00)	67.70 (58.00–82.50)	70.00 (69.60-80.70)	0.640
Weight gain during pregnancy in kg	13.00 (10.00-17.00)	11.40 (8.70-14.00)	13.60 (3.70-19.00)	0.480

Data are median (q₁-q₃), mean ± SD, or n (%). GDM: Gestational diabetes mellitus.